Circadian rhythms in major depressive disorder: mechanistic insights and therapeutic frontiers
Open Access
- 3 June 2026
- journal article
- review article
- Published by Taylor & Francis in Annals of Medicine
- Vol. 58 (1) , 2671594
Abstract
Major Depressive Disorder (MDD) has emerged as a leading cause of disability worldwide, affecting over 264 million people. Recent evidence reveals that disruption of circadian rhythms may be fundamental to MDD pathophysiology, opening new avenues for therapeutic intervention. This review synthesizes current understanding of the intricate relationship between circadian system disruption and MDD, highlighting molecular mechanisms and clinical implications. We examine evidence from genetic studies, clinical observations, and therapeutic trials. Patients with MDD exhibit profound alterations in circadian-regulated processes, including sleep-wake cycles, diurnal mood patterns, and metabolic functions. Genetic studies have identified variants in core clock genes, particularly CLOCK, TIMELESS, and CRY1, that correlate with both circadian disruption and MDD susceptibility. These genetic insights, combined with evidence of dysregulated hypothalamus-pituitary-adrenal axis function and abnormal melatonin signaling, suggest that circadian dysfunction may be causal in MDD pathogenesis rather than merely symptomatic. Emerging chronotherapeutic approaches, such as light therapy, sleep interventions, and targeted pharmacology, show significant potential for improving depressive symptoms. Personalized circadian-based treatments, guided by genetic and molecular markers, could transform MDD care. Advancing our understanding of the circadian-depression connection offers a promising path to revolutionizing treatment strategies.Keywords
This publication has 145 references indexed in Scilit:
- Neuroendocrine Profile in the Night Eating SyndromeCurrent Obesity Reports, 2013
- Efficacy of the novel antidepressant agomelatine for anxiety symptoms in major depressionHuman Psychopharmacology: Clinical and Experimental, 2013
- Overweight, Obesity, and DepressionArchives of General Psychiatry, 2010
- Neural Response to Catecholamine Depletion in Unmedicated Subjects With Major Depressive Disorder in Remission and Healthy SubjectsArchives of General Psychiatry, 2008
- Reduced Prefrontal Glutamate/Glutamine and γ-Aminobutyric Acid Levels in Major Depression Determined Using Proton Magnetic Resonance SpectroscopyArchives of General Psychiatry, 2007
- Genetic dissection of psychopathological symptoms: Insomnia in mood disorders and CLOCK gene polymorphismAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2003
- Association Between Serotonin Transporter Gene Promoter Polymorphism(5HTTLPR) and Behavioral Responses to Tryptophan Depletion in Healthy Women With and Without Family History of DepressionArchives of General Psychiatry, 2002
- Behavioral and Neuroendocrine Characteristics of the Night-Eating SyndromeJAMA, 1999
- A Controlled Trial of Timed Bright Light and Negative Air Ionization for Treatment of Winter DepressionArchives of General Psychiatry, 1998
- Seasonal Affective DisorderArchives of General Psychiatry, 1984